KCL Medical Foundation recently announced its partnership with U2medtek to expand their cooperation and enhance the healthcare business. Through this collaboration, KCL Medical Foundation will introduce U2medtek’s SinusView diagnostic equipment, offering an innovative and differentiated approach to traditional sinus exams.
Founded in 1996, KCL Medical Foundation has been a leading clinical laboratory that drives continuous innovation and change in the healthcare industry. The foundation operates accredited laboratories recognized by organizations such as CAP, the Korean Society of Diagnostic Laboratory Medicine, the Korean Association for Quality Control of Clinical Laboratories, and the Korean Society of Pathology, analyzing over 4,000 types of tests necessary for disease diagnosis and treatment. KCL has played an essential role in the development of clinical specimen testing in Korea through the introduction of new medical technologies and research.
U2medtek is a company that provides real-time health data analysis and personalized health management solutions, especially for chronic disease patients. Using near-infrared (NIR) technology and medical data analytics, U2medtek is revolutionizing sinus exams and digital blood glucose health management.
The newly introduced SinusView diagnostic equipment by KCL Medical Foundation uses near-infrared light transmission and image analysis technology to detect the presence of foreign objects in the sinuses. Unlike X-ray or CT scans, SinusView does not involve radiation exposure, making it safe for people of all ages to undergo testing without concern.
The SinusView device, enhanced with AI technology, offers greater accuracy than X-rays and achieves over 80% alignment with CT scans. It quantifies the severity of sinusitis and classifies the severity into three levels (low, slightly high, very high), enabling doctors to provide more accurate treatment directions while helping patients easily understand the extent of their symptoms. This technology is expected to serve as a safer and more efficient alternative to traditional radiation-based diagnostic methods.
A representative from KCL Medical Foundation stated, “We are thrilled to offer better testing and diagnostic services to our patients through our collaboration with U2medtek. We will continue to lead innovation in healthcare and provide more convenient and safer options for patients.”
KCL Medical Foundation recently announced its partnership with U2medtek to expand their cooperation and enhance the healthcare business. Through this collaboration, KCL Medical Foundation will introduce U2medtek’s SinusView diagnostic equipment, offering an innovative and differentiated approach to traditional sinus exams.
Founded in 1996, KCL Medical Foundation has been a leading clinical laboratory that drives continuous innovation and change in the healthcare industry. The foundation operates accredited laboratories recognized by organizations such as CAP, the Korean Society of Diagnostic Laboratory Medicine, the Korean Association for Quality Control of Clinical Laboratories, and the Korean Society of Pathology, analyzing over 4,000 types of tests necessary for disease diagnosis and treatment. KCL has played an essential role in the development of clinical specimen testing in Korea through the introduction of new medical technologies and research.
U2medtek is a company that provides real-time health data analysis and personalized health management solutions, especially for chronic disease patients. Using near-infrared (NIR) technology and medical data analytics, U2medtek is revolutionizing sinus exams and digital blood glucose health management.
The newly introduced SinusView diagnostic equipment by KCL Medical Foundation uses near-infrared light transmission and image analysis technology to detect the presence of foreign objects in the sinuses. Unlike X-ray or CT scans, SinusView does not involve radiation exposure, making it safe for people of all ages to undergo testing without concern.
The SinusView device, enhanced with AI technology, offers greater accuracy than X-rays and achieves over 80% alignment with CT scans. It quantifies the severity of sinusitis and classifies the severity into three levels (low, slightly high, very high), enabling doctors to provide more accurate treatment directions while helping patients easily understand the extent of their symptoms. This technology is expected to serve as a safer and more efficient alternative to traditional radiation-based diagnostic methods.
A representative from KCL Medical Foundation stated, “We are thrilled to offer better testing and diagnostic services to our patients through our collaboration with U2medtek. We will continue to lead innovation in healthcare and provide more convenient and safer options for patients.”